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Abstract
Studies of a possible role of tyrosine phosphorylation in the secretory process in rat pancreatic acinar cells provide
conflicting conclusions. Recent studies show that tyrosine phosphorylation of the focal adhesion kinase, p125FAK and the
cytoskeletal protein, paxillin, may mediate a number of cellular changes and this phosphorylation is dependent on the
activation of the small GTP binding protein, p21Rho (Rho). In this work we have investigated the role of tyrosine
phosphorylation of each of these proteins and of the activation of Rho in pancreatic enzyme secretion. Pretreatment with
genistein, a tyrosine kinase inhibitor, decreased CCK-8-stimulated tyrosine phosphorylation of p125FAK and paxillin and
CCK-8-stimulated amylase secretion by more than 60%, raising the possibility that tyrosine phosphorylation of these two
proteins could be important in the ability of CCK-8 to stimulate amylase release. However, genistein did not alter the
amylase release stimulated by TPA but inhibited TPA-stimulated p125FAK and paxillin tyrosine phosphorylation by 70%.
Pretreatment with C3 transferase, which specifically inactivates Rho, causes a decrease in CCK-8-induced maximal amylase
release by 33%. Moreover, C3 transferase pretreatment causes a 48% and a 38% decrease in the tyrosine phosphorylation of
p125FAK and paxillin by CCK-8, respectively. Pretreatment with different concentrations of cytochalasin D, an actin
cytoskeleton assembly inhibitor, completely inhibited CCK-8-stimulated tyrosine phosphorylation of p125FAK and paxillin
without having any effect on either the potency or efficacy of CCK-8 at stimulating amylase release. Furthermore,
cytochalasin D completely inhibited TPA-stimulated tyrosine phosphorylation of both proteins without affecting TPA-
stimulated amylase release. These results show that tyrosine phosphorylation of p125FAK and paxillin is not required for
CCK-8 stimulation of enzyme secretion. However, our results suggest Rho is involved in the CCK-8 stimulation of amylase
release by a parallel pathway to its involvement in the CCK-8-stimulated tyrosine phosphorylation of p125FAK and
paxillin. 0167-4889 / 98 / $ ^ see front matter ß 1998 Elsevier Science B.V. All rights reserved.
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1. Introduction
Extensive studies show that CCKA receptor occu-
pation causes activation of phospholipase C (PLC)
resulting in generation of diacylglycerol, increased
0167-4889 / 98 / $ ^ see front matter ß 1998 Elsevier Science B.V. All rights reserved.
PII: S 0 1 6 7 - 4 8 8 9 ( 9 8 ) 0 0 0 7 2 - X
* Corresponding author. Fax: +1 (301) 402-0600;
E-mail : robertj@bdg10.niddk.nih.gov
BBAMCR 14347 8-9-98
Biochimica et Biophysica Acta 1404 (1998) 412^426
inositol 1,4,5-triphosphate with subsequent activa-
tion of protein kinase C (PKC), release of intracel-
lular calcium, and that these pathways are likely
important in mediating many of the cellular e¡ects
of CCK [1,2]. However, recent studies suggest that
activation of nonreceptor tyrosine kinases is likely
also an important mediator for some of the cellular
e¡ects of CCK and a possible role of tyrosine phos-
phorylation in the regulation of pancreatic secretion
has been proposed [3^8]. However, these studies
provide con£icting conclusions about the impor-
tance of tyrosine phosphorylation in the ability of
di¡erent secretagogues to stimulate pancreatic en-
zyme secretion. A number of studies demonstrate
that genistein, a tyrosine kinase inhibitor, inhibits
both tyrosine phosphorylation and amylase release
stimulated by some secretagogues, but not by others
[3,4,6]. On the contrary, another study [5] reports
the opposite e¡ect with increased phosphatase activ-
ity causing enhanced calcium-dependent amylase
secretion. Furthermore, con£icting results are re-
ported on the relationship between tyrosine phos-
phorylation and secretion in other cell systems. In
adrenal chroma⁄n cells and in human endothelial
cells tyrosine kinases enhance secretion [9,10]; how-
ever, in parotid cells the opposite situation occurs
[11,12].
We have recently demonstrated in rat pancreatic
acini that CCK rapidly increases the tyrosine phos-
phorylation of the cytosolic focal adhesion kinase,
p125FAK, and the cytoskeletal protein, paxillin [13].
Moreover, we have demonstrated that, similar to
CCK-stimulated enzyme secretion [1,2], both PLC-
dependent and PLC-independent mechanisms medi-
ate CCK-stimulated tyrosine phosphorylation of
p125FAK and paxillin [14]. Recent studies [8,15^18]
suggest that the tyrosine phosphorylation of
p125FAK and paxillin may be important in mediating
a number of cellular changes such as growth, cell
motility or cell shape in response to activation of a
number of G protein-coupled receptors for neuro-
peptides. One recent study [7] has suggested tyrosine
phosphorylation of paxillin may be important in me-
diating CCK-8-stimulated amylase release. A number
of studies demonstrate that activation of the small
GTP binding protein, Rho, is important for CCK
and these other neuropeptides to cause tyrosine
phosphorylation of these two proteins [8,14,19,20].
However, the functional role of p125FAK and paxillin
or Rho in pancreatic acini remains unclear.
The purpose of the present study was to determine
the possible role of the tyrosine phosphorylation of
p125FAK and paxillin and activation of the small
GTP binding protein, Rho, in CCK stimulation of
amylase release from pancreatic acinar cells.
2. Materials and methods
2.1. Materials
Male Sprague-Dawley rats (150^200 g) were ob-
tained from the Small Animals Section, Veterinary
Resources Branch, NIH, Bethesda, MD or from
the Animal Farm, Faculty of Veterinary, UEX,
Spain; puri¢ed collagenase (type CLSPA) from Wor-
thington Biochemicals, Freehold, NJ; COOH-termi-
nal octapeptide of cholecystokinin (CCK-8) was ob-
tained from Peninsula Laboratories, Belmont, CA;
phosphate bu¡er saline (PBS), pH 7.4, from Bio-
£uids, Rockville, MD; anti-focal adhesion kinase
(p125FAK) monoclonal antibody, anti-paxillin mono-
clonal antibody and anti-phosphotyrosine monoclo-
nal antibody (PY20) from Transduction Laborato-
ries, Lexington, KY; recombinant protein A-
agarose and anti-phosphotyrosine monoclonal anti-
body (4G10) from Upstate Biotechnology Inc., Lake
Placid, NY; anti-RhoA polyclonal antibody (sc-179),
RhoA-antigen peptide (sc-179P) and anti-RhoA
monoclonal antibody (sc-418) from Santa Cruz Bio-
technology, Santa Cruz, CA; 12-O-tetradecanoyl-
phorbol 13-acetate (TPA) and deoxycholic acid
from Calbiochem, La Jolla, CA; soybean trypsin in-
hibitor (SBTI), dimethyl sulfoxide (DMSO) and Tri-
ton X-100 from Sigma, St. Louis, MO; phenylmetha-
nesulfonyl £uoride (PMSF) from Fluka,
Ronkonkoma, MY; basal medium Eagle amino
acids (U100) and basal medium Eagle vitamin solu-
tion (U100) from Gibco Laboratories, Grand Island,
NY; bovine serum albumin (BSA) fraction V from
Miles Inc., Kankakee, IL; aprotinin, leupeptin and
4-[2-hydroxyethyl]-1-piperazone ethanesulfonic acid
(HEPES) from Boehringer Mannheim Biochemicals,
Indianapolis, IN; myo-[2-3H]inositol (16^20 Ci/
mmol) from New England, Boston, MA; Clostridium
botulinum C3 transferase (C3 transferase) from List
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Biological Laboratories Inc., Campbell, CA; rabbit
anti-mouse IgG and anti-mouse IgG-horseradish per-
oxidase conjugate from Pierce, Rockford, IL; so-
dium dodecyl sulfate (SDS), 2-mercaptoethanol, pro-
tein assay dye reagent, Tris/Glycine/SDS bu¡er (10
times concentrated) and Tris/Glycine bu¡er (10 times
concentrated) from BIO-RAD, Richmond, CA;
[32P]NAD (s 1000 Ci/mmol), Hyper¢lm ECL, en-
hanced chemiluminescence detection reagents, from
Amersham, Arlington Heights, IL and nitrocellulose
membrane from Schleicher and Schuell, Keene, NH.
2.2. Methods
2.2.1. Tissue preparation
Dispersed rat pancreatic acini were prepared ac-
cording to the modi¢cations [21] of the procedure
published previously [22]. Unless otherwise stated,
the standard incubation solution contained (mM):
HEPES (25.5) [pH 7.4]; NaCl (98); KCl (6);
NaH2PO4 (2.5); sodium pyruvate (5); sodium fuma-
rate (5); sodium glutamate (5); glucose (11.5); CaCl2
(0.5); MgCl2 (1); glutamine (2); albumin 1% (w/v);
trypsin inhibitor 1% (w/v); vitamin mixture, 1% (v/v)
and amino acid mixture, 1% (w/v). The incubation
solution was equilibrated with 100% O2 and all in-
cubations were performed with 100% O2 as the gas
phase.
2.2.2. Amylase release
Amylase release was measured using the procedure
published previously [21,22]. Amylase activity was,
unless otherwise stated, determined after a 30 min
incubation using the Phadebas reagent and was ex-
pressed as percentage of cellular amylase released
into the extracellular medium during the incubation.
2.2.3. Measurement of inositol phosphates
Changes in total inositol phosphates were deter-
mined in pancreatic acini as described previously
[23]. Brie£y, dispersed acini were incubated with
100 WCi/ml of myo-[2-3H]inositol for 120 min. Total
[3H]inositol phosphate ([3H]IP) was isolated by anion
exchange chromatography as described previously
[23,24].
2.2.4. Immunoprecipitation
Immunoprecipitation of p125FAK and paxillin was
performed as described previously [13,14]. Brie£y,
dispersed acini from one rat were preincubated
with standard incubation solution without or with
di¡erent inhibitors for 2 h at 37‡C. Aliquots (1 ml)
were then incubated with CCK-8 (0.1 nM) or TPA
(30 nM) for 5 min at 37‡C. Acini were then separated
by centrifugation, washed with phosphate bu¡er sa-
line with 0.2 mM Na3VO4 at 4‡C, centrifuged and
sonicated for 5 s at 4‡C in 1 ml of a solution con-
taining 50 mM Tris/HCl, pH 7.5, 150 mM NaCl, 1%
Triton X-100, 1% deoxycholate, 0.1% (w/v) NaN3,
1 mM EGTA, 0.4 mM EDTA, 2.5 Wg/ml aprotinin,
2.5 Wg/ml leupeptin, 1 mM PMSF and 0.2 mM
Na3VO4. Immunoprecipitation was carried out using
anti-phosphotyrosine monoclonal antibody (PY20),
rabbit anti-mouse IgG and protein A-agarose as de-
scribed previously [13,14]. The immunoprecipitates
were analyzed by SDS-polyacrylamide gel electro-
phoresis (PAGE) and Western blotting. For RhoA
immunoprecipitation studies the lysates (100 Wg/ml)
were incubated with 2.5 Wg of anti-RhoA polyclonal
antibody (sc-179) and 30 Wl of protein A-agarose
overnight at 4‡C. The immunoprecipitates were
washed three times with PBS and further analyzed
by SDS-PAGE and Western blotting.
2.2.5. Western blotting
Western blotting was performed as described pre-
viously [13,14]. Brie£y, proteins with molecular
masses higher than 60 kDa were transferred to
0.45-Wm pore size nitrocellulose membranes. Anti-
phosphotyrosine monoclonal antibody (4G10), anti-
p125FAK monoclonal antibody, and anti-paxillin
monoclonal antibody were used as described previ-
ously [13,14]. For studies involving RhoA, anti-
RhoA immunoprecipitates or equal amounts of cel-
lular proteins (30 Wg) from acinar lysates were frac-
tionated by SDS-PAGE using 14% polyacrylamide
gels. Proteins with molecular masses higher than
10 kDa were transferred to 0.2-Wm pore size nitro-
cellulose membranes. Membranes were blocked for
1 h at 25‡C using blotto and incubated for 2 h at
25‡C with 0.5 Wg/ml anti-RhoA monoclonal antibody
(sc-418). In all cases, after incubation with the pri-
mary antibody, membranes were washed twice for
10 min with blotto (5% nonfat dried milk in 50 mM
Tris/HCl pH 8.0, 2 mM CaCl2, 80 mM NaCl, 0.05%
(v/v) Tween 20, 0.02% NaN3) and incubated for 1 h
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at 25‡C with anti-mouse IgG-horseradish peroxidase
conjugate. The membranes were ¢nally washed
2 times for 10 min with blotto and 2 times for
10 min with washing solution (50 mM Tris/HCl pH
8.0, 2 mM CaCl2, 80 mM NaCl, 0.05% (v/v) Tween
20), incubated with enhanced chemiluminescence de-
tection reagents (ECL) for 60 s and exposed to Hy-
per¢lm ECL. The density of bands on the ¢lm was
measured using a scanning densitometer (Molecular
Dynamics, Sunnyvale, CA). When reprobing was
necessary, membranes were stripped of bound anti-
bodies by incubating in stripping bu¡er (62.5 mM
Tris/HCl pH 6.7, 100 mM 2-mercaptoethanol, 2%
(w/v) sodium dodecyl sulfate) at 50‡C for 30 min
with occasional agitation. Membranes were then in-
cubated twice for 20 min with washing solution and
blocked overnight at 4‡C using blotto. Immunode-
tection was performed as described previously
[13,14].
2.2.6. ADP-ribosylation
Dispersed acini from one rat pancreas was treated
for 2 h at 37‡C either in the absence or presence of
25 Wg/ml of C3 transferase. Acini were washed with
phosphate bu¡er saline at 4‡C, centrifuged and soni-
cated for 5 s at 4‡C in 1 ml of a solution containing
50 mM Tris/HCl, pH 7.5, 150 mM NaCl, 0.1% (w/v)
NaN3, 1 mM EGTA, 0.4 mM EDTA, 2.5 Wg/ml
aprotinin, 2.5 Wg/ml leupeptin, 1 mM PMSF and
0.2 mM Na3VO4. Lysates were centrifuged at
14 000 rpm for 15 min and protein concentration
was measured by the Bio-Rad protein assay. ADP-
ribosylation was carried out as described by Yama-
moto et al. [25]. The standard assay mixture con-
tained 100 mM Tris/HCl, pH 8.0, 10 mM thymidine,
5 mM dithiothreitol, 5 mM MgCl2, 50 WM [32P]NAD
(s 1000 Ci/mmol), 0.5 Wg C3 exoenzyme and 50 Wg
of lysate proteins in a total volume of 100 Wl was
incubated at 30‡C for 1 h and the reaction was ter-
minated by addition of 11 Wl of 70% trichloroacetic
acid. After being chilled on ice for 20 min, the mix-
ture was centrifuged at 4‡C at 14 000 rpm for 15 min.
The precipitates recovered were washed 2 times with
10% trichloroacetic acid, 2 times with distilled water
and dissolved in 25 Wl of the Laemmli sample bu¡er
and subjected to 14% SDS-polyacrylamide gel elec-
trophoresis. The gels were dried and the radioactivity
was measured in a phosphoimager (Molecular Dy-
namics, Sunnyvale, CA). After the phosphoimager,
autoradiography of the gels was performed.
2.2.7. Statistical methods
Results are expressed as mean þ S.E.M. Multiple
comparisons in the dose-response curves were per-
formed using an analysis of variance with the Dun-
nett’s test for comparison with control. Other com-
parisons were made using the unpaired Student’s
t-test. Values with P6 0.05 were considered signi¢-
cant.
3. Results
Treatment of acinar cells for 5 min with 0.1 nM of
CCK-8 causes a marked increase in the tyrosine
phosphorylation of at least ¢ve proteins with molec-
ular weights s 60 kDa (the apparent molecular
masses of these proteins was 170, 145, 120, 95 and
75 kDa) as revealed by immunoprecipitation of pan-
creatic acinar cell lysates with anti-phosphotyrosine
monoclonal antibody (PY20) followed by Western
blotting of the immunoprecipitates using a second
anti-phosphotyrosine monoclonal antibody (4G10)
(Fig. 1, top left panel). Moreover, CCK-8 (0.1 nM)
causes a marked increase in the tyrosine phosphor-
ylation of p125FAK and paxillin as revealed by re-
probing the same membranes after stripping using
a speci¢c anti-p125FAK monoclonal antibody and a
speci¢c anti-paxillin monoclonal antibody (Fig. 1,
top middle panel). Pretreatment of pancreatic acinar
cells with genistein at 300 WM for 30 min caused a
signi¢cant decrease in the enhanced tyrosine phos-
phorylation induced by CCK-8 in each of ¢ve pro-
teins with molecular weights s 60 kDa (Fig. 1, top
middle panel). Pretreatment with genistein decreased
CCK-8-stimulated tyrosine phosphorylation of
p125FAK and paxillin by 67 þ 14% and 64.5 þ 8%, re-
spectively (Fig. 1, top middle panel). Immunopreci-
pitation of cell lysates with either anti-p125FAK
monoclonal Ab or anti-paxillin monoclonal Ab fol-
lowed by Western blotting with the same antibodies
revealed that the amounts of p125FAK and paxillin
immunoprecipitated from genistein-treated or -un-
treated pancreatic acinar cells were comparable
(Fig. 1, top right panel). Pretreatment of pancreatic
acinar cells for 30 min with 300 WM genistein caused
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a 70.5 þ 8.5% inhibition of the maximal stimulation
seen with 0.3 nM CCK-8 (Fig. 1, bottom panel). The
fact that 300 WM genistein caused a similar degree of
inhibition of CCK-8 stimulation of tyrosine phos-
Fig. 1. E¡ect of the tyrosine kinase inhibitor, genistein on CCK-8 stimulation of protein tyrosine phosphorylation (top panels) and
amylase release (bottom panel) in rat pancreatic acinar cells. Acini were preincubated with 300 WM genistein or vehicle alone (control)
(0.1% v/v DMSO alone) at 37‡C for 30 min. After centrifugation, acini were resuspended in fresh standard incubation solution con-
taining the same concentration of genistein, incubated for 5 min at 37‡C for tyrosine phosphorylation studies or for 30 min for amy-
lase release studies with or without 0.1 nM CCK-8. Top panels : After washing with PBS with 0.2 mM of Na3VO4, acini were then
lysed. Whole cell lysates were immunoprecipitated (IP) with anti-phosphotyrosine monoclonal Ab (PY20) (KPTyr) or anti-p125FAK
mAb (Kp125FAK) or anti-paxillin mAb (Kpaxillin) and separated by SDS-PAGE followed by transfer of proteins of molecular
weights 60 kDa to a nitrocellulose membrane. Western blotting (WB) was performed with KPTyr (4G10) (top left panel) or after
stripping was performed as described in Section 2.2, with Kp125FAK and Kpaxillin (top middle panel). Finally, membranes shown in
the top right panel were probed with Kp125FAK or with paxillin. Bands were visualized using ECL. Arrows on the right indicate the
position of p125FAK and paxillin tyrosine phosphorylation proteins. These results are representative of at least three others. Bottom
panel: After the incubation with the indicated concentration of CCK-8, acini were pelleted and amylase activity in the supernatant
was determined. Amylase activity was expressed as the percentage of cellular amylase released into the extracellular medium during
the incubation. Results are means þ S.E.M. obtained from four separate experiments in which each point was determined in duplicate
(*P6 0.05 compared to the CCK-8 value).
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phorylation of p125FAK and paxillin and CCK-8-
stimulated amylase release raised the possibility
that tyrosine phosphorylation of these two proteins
could be important in the ability of CCK-8 to stim-
ulate amylase release.
After CCK-8 binds to its receptor it causes activa-
tion of phospholipase C, which promotes the hydrol-
ysis of phosphatidyl-inositol 4,5-bisphosphate, lead-
ing to production of diacylglycerol and IP3 which, in
turn, causes protein kinase C (PKC) activation and
enzyme secretion [1,2]. In a previous study in rat
pancreatic acinar cells, we showed that the phorbol
ester TPA, which directly activates PKC, stimulated
an increase in the tyrosine phosphorylation of
p125FAK and paxillin [14]. Pretreatment of pancreatic
acinar cells for 30 min with 300 WM genistein caused
a 73 þ 13% and 70 þ 15% decrease in TPA-stimulated
p125FAK (Fig. 2, top and bottom panels) and paxillin
(Fig. 2, top panel) tyrosine phosphorylation, respec-
tively. However, pretreatment for 30 min with genis-
tein (300 WM) did not alter the amylase release stimu-
lated by TPA (30 nM) (Fig. 2, bottom panel). These
results suggest that amylase release due to the acti-
vation of PKC is unlikely to be coupled to tyrosine
phosphorylation of p125FAK and paxillin; however,
it does not exclude the possibility that other intra-
cellular pathways activated by CCK could be in-
volved in CCK-mediated amylase release and could
be coupled to tyrosine phosphorylation of p125FAK
or paxillin.
In a recent study [14] we demonstrated that the
ability of CCK to cause tyrosine phosphorylation
of p125FAK and paxillin, similar to a number of other
neuropeptides [20,26], is critically dependent on the
activation of the small GTP-binding protein, Rho.
To investigate further the possible relationship be-
tween the stimulation of tyrosine phosphorylation
of p125FAK and paxillin and enzyme secretion we
determined the importance of the participation of
Rho in both processes. To establish that RhoA was
present in pancreatic acini we ¢rst performed an im-
munoprecipitation using polyclonal antibody against
RhoA and immunoblotted with a monoclonal anti-
body against RhoA. As shown in Fig. 3 (panel A) we
detected a band of molecular weight 22 kDa in pan-
creatic acini. This band was not observed when im-
munoprecipitation was performed using the anti-
RhoA pAb preabsorbed with 10-fold excess amount
of RhoA-antigen peptide (Fig. 3, panel A, lane 2).
Treatment with Clostridium botulinum C3 transferase
(C3 transferase) causes ADP-ribosylation of Rho
which inactivates Rho [27^29]. To establish whether
the C3 transferase treatment was inactivating Rho in
pancreatic acinar cells we used two di¡erent ap-
Fig. 2. E¡ect of genistein on TPA stimulation of p125FAK and
paxillin tyrosine phosphorylation and amylase release in rat
pancreatic acinar cells. Acini were preincubated with 300 WM
genistein or vehicle alone (control) (0.1% v/v DMSO alone) at
37‡C for 30 min. Acini were then incubated for a further 5 min
with no additions or with 30 nM TPA (top panel) and analyzed
by Western blotting using anti-p125FAK and anti-paxillin mAbs
performed as described in the legend to Fig. 1 and Section 2.2.
These results are representative of at least three others. In the
bottom panel is shown the e¡ect of genistein treatment on
TPA-stimulated p125FAK tyrosine phosphorylation and amylase
release. The values for p125FAK tyrosine phosphorylation are
the means þ S.E.M. (n = 4) expressed as the percentage of the
maximal increase caused by 30 nM TPA (3.7 þ 0.6-fold in-
crease). For amylase release studies, after genistein treatment,
acinar cells were then incubated for a further 30 min with
30 nM TPA and amylase release was determined as described
in Section 2.2. Results are means þ S.E.M. from four separate
experiments in duplicate and the data are expressed as percent-
age of the maximal increase in amylase release caused by 30 nM
TPA in acinar cells not treated with genistein. The control and
TPA-stimulated values for amylase release were 4.5 þ 0.8% and
11.5 þ 2.9% of total cellular amylase, respectively.
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proaches. In one approach we used the observation
that ADP-ribosylation of Rho results in a marked
diminution in the ability of the anti-RhoA pAb to
interact with RhoA in cellular lysates [30,31]. Pre-
treatment of acinar cells with C3 transferase (25
Wg/ml) for 2 h caused a marked decrease in the
immunoreactive RhoA present in acinar lysates as
shown in Fig. 3 (panel B). In the second approach
we assessed ADP-ribosylation after pretreatment
with C3 transferase. Pretreatment with C3 transfer-
ase caused a marked decrease in the amount of the
ADP-ribosylated substrate in acinar cell lysates, sug-
gesting that this substrate protein had been ADP-
ribosylate in situ (Fig. 3, panel C). There was only
one substrate ribosylated by C3 transferase and this
substrate had a molecular weight identical to that of
immunoreactive RhoA (Fig. 3). However, the activa-
tion of PLC by CCK-8 (0.1 and 10 nM) was not
altered after pretreatment with C3 transferase (25
Wg/ml) (Table 1). Pretreatment with C3 transferase
caused a 48 þ 6% and 38 þ 11% decrease in the tyro-
sine phosphorylation of p125FAK and paxillin by
CCK-8 (0.1 nM), respectively (Fig. 4, top panel,
lanes 3 and 4), without having any signi¢cant e¡ect
on basal tyrosine phosphorylation (Fig. 4, top panel,
lanes 1 and 2). Moreover, pretreatment with C3
transferase caused a signi¢cant decrease in maximal
CCK-8-stimulated amylase release of 33 þ 3% (Fig. 4,
Fig. 3. Identi¢cation of the small GTP-binding protein RhoA and e¡ects of C3 transferase on the total immunodetectable RhoA and
extent of ADP ribosylation. Panel A: Immunoprecipitates were performed using an anti-RhoA polyclonal antibody. In lane 2, the
anti-RhoA polyclonal antibody was preincubated with RhoA-antigen peptide for 2 h before immunoprecipitation. Immunoprecipitates
were subjected to SDS-PAGE on a 14% gel. RhoA was identi¢ed by Western blotting using an anti-RhoA monoclonal antibody. The
results are representative of at least three others. Panel B: Pancreatic acinar cells were incubated for 2 h in the presence or absence of
C3 transferase (25 Wg/ml) and then lysed. Acinar lysate proteins (30 Wg) were subjected to SDS-PAGE on a 14% gel. RhoA was iden-
ti¢ed by Western blotting using an anti-RhoA mAb. Panel C: Pancreatic acinar cells were pretreated for 2 h at 37‡C either in the ab-
sence or presence of 25 Wg/ml of C3 transferase and then lysed. The cell lysates were used for ADP-ribosylation as described in Sec-
tion 2.2. The autoradiogram shown is representative of three others. Left lane: control acinar cells lysates; right lane: lysates of C3
transferase-treated acinar cells.
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bottom panel). The e¡ect of the C3 transferase was
entirely on the e⁄cacy of CCK-8, because C3 trans-
ferase treatment had no e¡ect on basal secretion and
the CCK-8 concentration causing a half-maximal ef-
fect for amylase release was similar in acinar cells
pretreated with C3 transferase or in acinar cells with-
out pretreatment (i.e. 10.5 þ 0.25 vs. 13.5 þ 0.2 pM,
n = 4) (Fig. 4, bottom panel).
In a previous study in rat pancreatic acinar cells,
we showed that the phorbol ester TPA stimulation of
p125FAK and paxillin tyrosine phosphorylation were
dependent on the activation of Rho [14]. Therefore,
to investigate the e¡ect of Rho inactivation on
changes caused by PKC activation, we explored the
e¡ect of C3 transferase on the action of TPA. Treat-
ment of pancreatic acinar cells with 30 nM of TPA
for 5 min caused a 2.7 þ 0.6- and 1.5 þ 0.5-fold in-
crease (experimental/control) in the tyrosine phos-
phorylation of p125FAK and paxillin, respectively
(Fig. 5, top panel) and treatment for 30 min caused
a 1.7 þ 0.3-fold increase (experimental/control) in
Fig. 4. E¡ect of the Botulinum clostridium C3 transferase on
CCK-8 stimulation of p125FAK and paxillin tyrosine phosphory-
lation and amylase release in rat pancreatic acinar cells. Pancre-
atic acinar cells were pretreated for 2 h at 37‡C either in the
absence or presence of 25 Wg/ml of C3 transferase. Top panel:
Acini were then incubated for a further 5 min with no addi-
tions (control or C3) or with 0.1 nM CCK-8 and then lysed.
Whole cell lysates were immunoprecipitated with anti-phospho-
tyrosine monoclonal Ab (PY20) and separated by SDS-PAGE
followed by transfer of proteins of molecular weight s 60 kDa
to a nitrocellulose membrane. Membranes were probed with
anti-p125FAK mAb and anti-paxillin mAb. Bands were visual-
ized using ECL. These results are representative of at least
three others. Bottom panel: After C3 transferase treatment aci-
nar cells were then incubated for a further 30 min with the in-
dicated concentration of CCK-8 and amylase release was deter-
mined as described in Section 2.2. Results are means þ S.E.M.
from four separate experiments in duplicate and the data are
expressed as the percentage of the total cellular amylase re-
leased into the extracellular space during the incubation. Con-
trol and maximal stimulation with 0.1 nM CCK-8 in acini not
treated with C3 transferase was 3.5 þ 0.5% and 14.5 þ 1.5% of
the total cellular amylase and 3.3 þ 0.5% and 11.0 þ 1.5% of to-
tal cellular amylase in acini treated with C3 transferase. Aster-
isks indicate signi¢cant di¡erences as compared to non-C3
transferase treatment acinar cells (P6 0.05 with the Dunnett’s
test for comparison between groups).
C
Table 1
E¡ects of C3 transferase on CCK-8 stimulation of [3H]IP gen-
eration in rat pancreatic acinar cells
[3H]IP (experimental/control)
Secretagogue No treatment C3 transferase
None 1 0.9 þ 0.5
CCK-8 (0.1 nM) 4.4 þ 0.7 4.1 þ 0.6
CCK-8 (10 nM) 14.8 þ 1.5 15.0 þ 1.7
Pancreatic acinar cells were pretreated for 2 h at 37‡C either in
the absence or presence of 25 Wg/ml of C3 transferase and then
incubated for a further 30 min with no additions (control) or
with 0.1 nM and 10 nM CCK-8. Total [3H]IP generation was
determined as described in Section 2.2 and expressed as experi-
mental vs. control. The [3H]IP value for the control was
2550 þ 200 dpm. Results are means þ S.E.M. from four separate
experiments.
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amylase secretion. Pretreatment of pancreatic acinar
cells for 2 h with 25 Wg/ml C3 transferase caused a
60 þ 6% and 60 þ 6% decrease in the TPA-stimulated
p125FAK (Fig. 5, top and bottom panels) and paxillin
tyrosine phosphorylation (Fig. 5, top panel), respec-
tively. Moreover, pretreatment for 2 h with C3 trans-
ferase (25 Wg/ml) decreased TPA-stimulated amylase
release by 53 þ 12% (Fig. 5, bottom panel). There-
Fig. 6. E¡ect of cytochalasin D on CCK-8 stimulation of
p125FAK and paxillin tyrosine phosphorylation and amylase se-
cretion. Top panel: Acinar cells were treated for 2 h in the ab-
sence or presence of various concentrations of cytochalasin D
as indicated and then incubated for a further 5 min with no ad-
ditions (control) or with 0.1 nM CCK-8. The cells were then
lysed, tyrosine phosphorylated proteins were immunoprecipi-
tated using anti-phosphotyrosine mAb (PY20) and the immuno-
precipitates were analyzed by Western blotting using anti-
p125FAK mAb and anti-paxillin mAb as described in Section
2.2. These results are representative of at least three others.
Bottom panel: Acinar cells were treated for 2 h either in the
absence or presence of 3 WM cytochalasin D and then incu-
bated for a further 30 min with the indicated concentrations of
CCK-8 and amylase release was determined as described in Sec-
tion 2.2. Results are expressed as the percentage of the total
cellular amylase released during the incubation. Results are
means þ S.E.M. from four separate experiments with each value
determined in duplicate.
Fig. 5. E¡ect of C3 transferase on TPA stimulation of p125FAK
and paxillin tyrosine phosphorylation and amylase release in rat
pancreatic acinar cells. Acini were preincubated without or with
25 Wg/ml C3 transferase at 37‡C for 2 h. Acini were then incu-
bated for a further 5 min with no additions or with 30 nM
TPA (top panel) and then analyzed by Western blotting using
anti-p125FAK and anti-paxillin mAbs as described in the legend
to Fig. 1 and Section 2.2. These results are representative of at
least three others. In the bottom panel are shown the means
þ S.E.M. (n = 4) of the e¡ect of C3 transferase on TPA-stimu-
lated p125FAK tyrosine phosphorylation and TPA-stimulated
amylase release. Values are expressed as the percentage of the
maximal increase caused by 30 nM TPA which, for p125FAK
phosphorylation, was 2.7 þ 0.6-fold increase. For amylase re-
lease studies, after C3 transferase treatment acini were then in-
cubated for a further 30 min with 30 nM TPA and amylase re-
lease was determined as described in Section 2.2. Results are
means þ S.E.M. from four separate experiments in duplicate
and the data are expressed as percentage of the maximal in-
crease in amylase release caused by 30 nM TPA in acinar cells
not treated with C3 transferase. The control and TPA-stimu-
lated values for amylase release were 3.5 þ 0.5% and 9.4 þ 1.8%
of total cellular amylase, respectively.
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fore, C3 transferase caused a similar degree of reduc-
tion in CCK-8- and TPA-stimulated amylase release
and tyrosine phosphorylation of p125FAK and paxil-
lin.
A recent study by us [14] demonstrates that pre-
treatment of pancreatic acinar cells with cytochalasin
D, which is a speci¢c inhibitor of assembly of the
actin cytoskeleton [32], completely inhibited CCK-8
stimulation of p125FAK and paxillin tyrosine phos-
phorylation. Similar results were reported with a
number of other neuropeptides in di¡erent tissues
[17,18,33]. To investigate further the relationship be-
tween stimulated amylase release and tyrosine phos-
phorylation of p125FAK and paxillin, we explored the
e¡ect of cytochalasin D on both functions. Pancre-
atic acinar cells were pretreated for 2 h with di¡erent
concentrations of cytochalasin D and then incubated
with CCK-8 (0.1 nM) (Fig. 6, top panel). Pretreat-
ment with cytochalasin D inhibited CCK-8-stimu-
lated p125FAK and paxillin tyrosine phosphorylation
in a concentration-dependent manner (Fig. 6, top
panel) with a complete inhibition achieved between
1 and 3 WM. When pancreatic acinar cells were
treated for 2 h with 3 WM cytochalasin D and then
incubated with various concentrations of CCK-8, the
preincubation with cytochalasin D had no e¡ect on
either the potency or e⁄cacy of CCK-8 at stimulat-
ing amylase release (Fig. 6, bottom panel). Therefore,
pretreatment with cytochalasin D, at a concentration
that completely inhibited CCK-8-stimulated p125FAK
and paxillin tyrosine phosphorylation, did not mod-
ify signi¢cantly the amylase release stimulated by
CCK-8 in pancreatic acinar cells (Fig. 6, bottom
panel). This result suggests that the integrity of the
actin cytoskeleton does not play an equally essential
role in both CCK-8-stimulated processes. Further-
more, pretreatment of pancreatic acinar cells for 2
h with 3 WM cytochalasin D completely inhibited
TPA-stimulated p125FAK (Fig. 7, top and bottom
panels) and paxillin tyrosine phosphorylation (Fig.
7, top panel). In contrast, pretreatment for 2 h
with cytochalasin D (3 WM) had no e¡ect on the
increase in amylase release caused by TPA (30 nM)
(Fig. 7, bottom left panel).
4. Discussion
The purpose of our study was to investigate the
possibility that stimulation of tyrosine phosphoryla-
tion of p125 focal adhesion kinase or of the cytoskel-
etal protein, paxillin, or activation of the small G
protein, Rho, could be important in mediating CCK-
Fig. 7. E¡ect of cytochalasin D on TPA stimulation of
p125FAK and paxillin tyrosine phosphorylation and amylase re-
lease in rat pancreatic acinar cells. Acini were preincubated
with 3 WM cytochalasin D or ethanol (0.1%) at 37‡C for 2 h.
Acini were then incubated for a further 5 min with no addi-
tions or with 30 nM TPA (top panel) and analyzed by Western
blotting using anti-p125FAK and anti-paxillin mAbs as described
in the legend to Fig. 1 and Section 2.2. These results are repre-
sentative of at least three others. In the bottom panel are
shown values for the e¡ect of cytochalasin D on TPA-stimu-
lated p125FAK tyrosine phosphorylation (right) or amylase re-
lease (left). For p125FAK tyrosine phosphorylation the values
are the means þ S.E.M. (n = 4) expressed as the percentage of
the maximal increase caused by 30 nM TPA (3.2 þ 0.3-fold in-
crease). For amylase release studies, after cytochalasin D treat-
ment, acinar cells were then incubated for a further 30 min
with 30 nM TPA and amylase release was determined as de-
scribed in Section 2.2. Results are means þ S.E.M. from four
separate experiments in duplicate and the data are expressed as
percentage of the maximal increase in amylase release caused
by 30 nM TPA in acinar cells not treated with cytochalasin D.
The control and TPA-stimulated values for amylase release
were 3.0 þ 0.6% and 8.7 þ 1.9% of total cellular amylase, respec-
tively.
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stimulated amylase secretion. Our results suggest that
tyrosine phosphorylation of these proteins is not
needed for CCK-stimulated amylase secretion, how-
ever, activation of Rho is important. This study was
undertaken because numerous recent studies demon-
strate that the activation of a number of G protein-
coupled receptors for neuropeptides can result in
stimulation of tyrosine phosphorylation of a number
of proteins [8,13,15,18,34]. This cascade is likely an
important signalling pathway for mediation of a
number of cellular changes such as in growth, cell
motility, and cell shape [15^18]. Recent studies
[15,16] suggest that the tyrosine phosphorylation of
p125FAK and paxillin may be particularly important
in mediating a number of these cellular e¡ects. A
previous study by us [13] demonstrated that CCK-8
causes rapid tyrosine phosphorylation of both
p125FAK and paxillin in rat pancreatic acinar cells
by activating both low and high a⁄nity sites of the
CCKA receptor. Furthermore, in a recent study [14]
we have demonstrated that, similar to CCK-stimu-
lated enzyme secretion [1,2], both phospholipase C
(PLC)-dependent and PLC-independent mechanisms
mediate CCK-stimulated tyrosine phosphorylation of
p125FAK and paxillin. Finally, a recent study [7] has
proposed that paxillin could be involved in CCK-
induced exocytosis in pancreatic acinar cells.
Results of a number of studies provide con£icting
conclusions about the importance of tyrosine phos-
phorylation of various proteins in the ability of CCK
and other secretagogues to stimulate pancreatic en-
zyme secretion. These studies have demonstrated that
genistein, a tyrosine kinase inhibitor, can partially
inhibit CCK-8-stimulated pancreatic enzyme secre-
tion [3,4,6,35]. Several studies have also demon-
strated that genistein can partially inhibit pancreatic
enzyme secretion caused by bombesin [6], CCK-OPE
[4], the calcium ionophore A23187 [4] and carbachol
[6], but not by TPA, VIP or secretin [3,4]. In one
study [6] the ability of genistein to cause inhibition
was only seen with low concentrations of CCK-8 or
carbachol, suggesting that enzyme secretion mediated
by the high a⁄nity CCKA or M3 muscarinic receptor
state might be di¡erentially a¡ected by genistein.
Other tyrosine kinase inhibitors such as erbastatin
[6] and herbimycin A [35] also inhibit CCK-8-stimu-
lated amylase secretion. On the contrary, Jena et al.
[5] reported that the addition of an exogenous re-
combinant tyrosine-speci¢c phosphatase to permea-
bilized pancreatic acinar cells enhanced calcium-de-
pendent amylase secretion. Furthermore, recent
studies in other cells show di¡ering results on the
relationship between tyrosine phosphorylation and
secretion. With catecholamine secretion from bovine
adrenal chroma⁄n cells [9], with prostacyclin release
from human endothelial cells [10], and with insulin
secretion from pancreatic L-cells and in pancreatic
islets [36], evidence suggests tyrosine phosphorylation
could be an important mediator in stimulated secre-
tion. Other studies show that in parotid cells a de-
crease in protein tyrosine kinase activity and an in-
crease in tyrosine phosphatase activity cause
stimulated amylase secretion [11,12]. Furthermore,
pretreatment of platelets with genistein caused a
marked reduction of the protein tyrosine phosphor-
ylation and an increase in the ionomycin-elicited se-
rotonin secretion [37]. Our results show that CCK-8-
stimulated amylase release was inhibited after pre-
treatment with genistein, which is in agreement
with previous studies in pancreatic acini [3,4]. More-
over, we show that CCK-8 stimulated the tyrosine
phosphorylation of at least ¢ve proteins with molec-
ular masses s 60 kDa and we identi¢ed two of these
proteins as focal adhesion kinase (p125FAK) and the
cytoskeleton-related protein, paxillin. Genistein in-
hibited both the tyrosine phosphorylation of
p125FAK and paxillin and the amylase release stimu-
lated by CCK-8 to a similar degree, raising the pos-
sibility that tyrosine phosphorylation of these two
proteins could be important in the ability of CCK-
8 to stimulate amylase release. To investigate further
the possible relationship between tyrosine phosphor-
ylation of p125FAK and paxillin and enzyme secretion
in pancreatic acini we used three di¡erent ap-
proaches. First, we investigated the role of PKC ac-
tivation in each because it has been shown that pre-
treatment with tyrosine kinase inhibitors had no
e¡ect on TPA-stimulated amylase secretion in pan-
creatic acini [3,4]. Second, we investigated the role of
the small GTP binding protein Rho in the CCK-8-
stimulated amylase secretion because it has been
shown to be needed for stimulation of p125FAK
and paxillin tyrosine phosphorylation in pancreatic
acini by CCK-8 [14]. Third, we investigated the e¡ect
on CCK-8 stimulation of amylase secretion of pan-
creatic acini pretreatment with cytochalasin D, which
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has been shown to inhibit p125FAK and paxillin ty-
rosine phosphorylation in every cell type tested in-
cluding pancreatic acini [14].
A previous study by us [14] demonstrated that the
activation of protein kinase C (PKC) with the phor-
bol ester, TPA, stimulated the tyrosine phosphoryla-
tion of p125FAK and paxillin in rat pancreatic acinar
cells. In the present study we found that genistein
inhibited TPA-stimulated tyrosine phosphorylation
of p125FAK and paxillin, but it had no e¡ect on
TPA-stimulated enzyme secretion. This result is con-
sistent with the ¢ndings in recent studies by others
[3,4] who proposed that CCKA receptor stimulation
of changes in intracellular calcium, but not PKC
activation, is likely coupled to activation of tyrosine
kinase and stimulation of pancreatic enzyme secre-
tion by CCK-8. In those studies [3,4] genistein had
no e¡ect on TPA-stimulated enzyme secretion but it
partially inhibited secretion mediated by changes in
cellular calcium. Our results suggest that it is unlikely
that stimulation of enzyme secretion by CCK-8 in
pancreatic acini is due to activation of PKC coupled
to CCK-8-stimulated tyrosine phosphorylation of
p125FAK and paxillin. Because the calcium iono-
phore, A23187, only causes a small increase in tyro-
sine phosphorylation of p125FAK and paxillin [14], it
was not possible to investigate the e¡ect of inhibitors
such as genistein on both A23187-stimulated amylase
release and tyrosine phosphorylation of p125FAK or
paxillin.
A recent study by us [14] demonstrated that stim-
ulation of p125FAK and paxillin tyrosine phosphory-
lation by CCK-8, similar to a number of other neu-
ropeptides [19,20], was critically dependent on the
activation of Rho. To examine the role of Rho in
CCK-stimulated amylase release and on CCK-stimu-
lated tyrosine phosphorylation of p125FAK and pax-
illin, we have used Clostridium botulinum C3 trans-
ferase, which speci¢cally inactivates Rho by ADP-
ribosylating it on asparagine residue 41 [27]. We
found that C3 transferase treatment inhibited the
e⁄cacy of CCK-8 in stimulating amylase release by
33% and that it caused a similar degree of reduction
in CCK-8-stimulated amylase release and tyrosine
phosphorylation of p125FAK and paxillin. Moreover,
C3 transferase pretreatment inhibited both TPA-
stimulated tyrosine phosphorylation of p125FAK
and paxillin and TPA-stimulated amylase release
more than 50%. The fact that C3 transferase (25
Wg/ml) pretreatment resulted in ribosylation of Rho
and its inactivation in our study was supported by a
diminution in the amount of immunodetectable
RhoA and by a diminution of the amount of ADP-
ribosylatable substrate present in cellular lysates
from acinar cells pretreated with C3 transferase. To
establish that C3 transferase pretreatment was not
having a general nonspeci¢c depressive action on
cell function we demonstrated that pretreatment
with C3 transferase had no e¡ect on the ability of
CCK-8 to stimulate changes in phosphoinositides at
maximal and supramaximal concentrations. The re-
sults with C3 transferase showing inhibition of both
CCK-8- and TPA-stimulated tyrosine phosphoryla-
tion of p125FAK and paxillin enzyme secretion raise
the possibility these processes could be coupled and
are contradictory with the results obtained with gen-
istein after PKC activation.
We have recently shown that pretreatment of pan-
creatic acini with cytochalasin D completely inhib-
ited CCK-8-stimulated p125FAK and paxillin tyrosine
phosphorylation [14], similar to its e¡ects on tyrosine
phosphorylation of these two proteins by a number
of other neuropeptides in other cell systems
[17,18,33]. In the present study we found that cyto-
chalasin D, which is an inhibitor of actin micro¢la-
ment assembly [32], completely inhibited CCK-8- or
TPA-stimulated tyrosine phosphorylation of
p125FAK and paxillin but did not impair CCK-8-
or TPA-stimulated amylase release. In previous stud-
ies [38,39] it has been shown that pretreatment of
acinar cells with cytochalasin B reduced the secretory
response to optimal CCK-8 concentrations. A num-
ber of factors could account for the di¡erences in the
results with cytochalasin B in the previous studies
and our results with cytochalasin D in the present
study. First, signi¢cant di¡erences have been re-
ported between cytochalasin B and D [32]. Cytocha-
lasin D is about 10 times more e¡ective than cyto-
chalasin B at binding to actin ¢laments and
cytochalasin B has important nonspeci¢c e¡ects
such as binding to the glucose transporter, whereas
binding of cytochalasin D to this transporter or to
other targets has not been reported [32]. Second, it
has been shown that the e¡ect of cytochalasin on
cellular processes depends on the concentration
used [32]. Third, a more recent study has reported
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that the actin cytoskeleton has direct inhibitory and
facilitory roles in regulated exocytosis in rat pancre-
atic acini [40]. Their results using intact and permea-
bilized acinar cells clearly showed that actin depoly-
merization was associated with CCK-8 stimulation of
exocytosis [40]. However, stimulation can not occur
without a minimal actin structure [40] and thus high
concentrations of cytochalasins can inhibit secretion.
With the di¡erent cytochalasins and concentrations
used, we do not know their relative speci¢c or non-
speci¢c e¡ects and, therefore, it makes it di⁄cult to
directly compare our results with these obtained in
previous studies [38,39]. In the present study we are
using a cytochalasin D concentration that inhibits
completely CCK-8 or TPA stimulation of p125FAK
and paxillin tyrosine phosphorylation but we have
not determined the degree of actin ¢laments disrup-
tion with this concentration. Our results imply that
cytochalasin D dissociates amylase secretion from
p125FAK and tyrosine phosphorylation in CCK-8-
stimulated acinar cells.
Numerous di¡erent small GTP-binding proteins
have been identi¢ed in rat pancreatic acinar cells
[41,42]. Recent studies report that small GTP-bind-
ing proteins are involved in signal transduction after
hormonal stimulation and this activity might have
implications for regulating vesicular transport of se-
cretory proteins or may be involved in regulated exo-
cytosis in these cells [41^44]. Studies in other cells
show that the small GTP-binding proteins of the
Ras superfamily play an essential role in intracellular
membrane transport, docking and exocytosis [45,46].
The small GTP-binding protein Rho has been impli-
cated in the signaling pathway that leads to L-hexo-
saminadase secretion in mast cells [45,47] and in rat
basophilic leukemia (RBL-2H3) cells [48]. In permea-
bilized mast cells pretreatment with C3 transferase or
in which a RhoGDP dissociation inhibitor (RhoG-
DI) is introduced to inhibit Rho activation, the se-
cretory response to GTPQS or calcium is reduced
[45,47]. Moreover, addition of a constitutively active
mutant of Rho to permeabilized mast cells enhances
calcium/ATP-induced hexosaminidase release and in
these cells the Rho’s e¡ect on secretion could be
dissociated from the well-established function of
Rho in mediating signals from receptors to the cy-
toskeleton [46]. In permeabilized RBL-2H3 cells pre-
treatment with C3 transferase reduced L-hexosamini-
dase release induced by calcium or by GTPQS plus
calcium [48]. Our results using the speci¢c Rho in-
activator, C3 transferase, showing a decrease in max-
imal enzyme stimulation by CCK-8 without altering
CCK-8-stimulated increases in inositol phosphates,
raise the possible involvement of the small GTP-
binding protein Rho in the stimulus-secretion cou-
pling in response to CCK-8 in rat pancreatic acinar
cells. Previously [14], and in the present study, we
demonstrate involvement of Rho in CCK-8 stimula-
tion of p125FAK and paxillin tyrosine phosphoryla-
tion; however, in the present study we demonstrate
that this is not coupled to CCK-8-stimulated enzyme
secretion. These results suggest Rho is likely involved
in two di¡erent parallel signaling cascades in that it
is important in the regulation of CCK-stimulated
p125FAK and paxillin tyrosine phosphorylation and
also partially mediates CCK-stimulated amylase re-
lease.
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